menu
    • menu

    Company profile for Zenas BioPharma

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in need. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational exce...
    Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and delivery of immune-based therapies for patients in need. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zenas BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1000 Winter St North Building, Suite 1200 Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zenasbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zenas Biopharma Presents Phase 2 Obexelimab Results In Relapsing
    Zenas Biopharma Presents Phase 2 Obexelimab Results In Relapsing

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234414/0/en/Zenas-BioPharma-Announces-Late-Breaking-Platform-Presentation-of-Results-from-Phase-2-MoonStone-Trial-of-Obexelimab-in-Relapsing-Multiple-Sclerosis-at-ACTRIMS-Forum-2026.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Zenas Biopharma To Present At Guggenheim Biotech Summit 2026
    Zenas Biopharma To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231918/0/en/Zenas-BioPharma-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Zenas BioPharma Grants Inducement Awards Under Nasdaq Rule
    Zenas BioPharma Grants Inducement Awards Under Nasdaq Rule

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220558/0/en/Zenas-BioPharma-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Zenas Biopharma Reports Phase 3 Success For Obexelimab In IgG4-Rd
    Zenas Biopharma Reports Phase 3 Success For Obexelimab In IgG4-Rd

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212626/0/en/Zenas-BioPharma-Announces-Positive-Results-from-Phase-3-INDIGO-Registrational-Trial-of-Obexelimab-in-Immunoglobulin-G4-Related-Disease-IgG4-RD.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Zenas BioPharma Issues Inducements Under Nasdaq Rule 5635(c)(4)
    Zenas BioPharma Issues Inducements Under Nasdaq Rule 5635(c)(4)

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208740/0/en/Zenas-BioPharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    InnoCare's Orelabrutinib Meets Primary Endpoint in Phase 2b SLE
    InnoCare's Orelabrutinib Meets Primary Endpoint in Phase 2b SLE

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205293/0/en/Zenas-BioPharma-s-Partner-InnoCare-Pharma-Announces-Achievement-of-Primary-Endpoint-in-Phase-2b-Study-of-Orelabrutinib-a-BTK-Inhibitor-for-Systemic-Lupus-Erythematosus.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search